Brief: vTv Therapeutics Announces Restructuring To Prioritize Its Lead Program And Focus Operations
06/12/2021 22:31
Dec 6 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES RESTRUCTURING TO PRIORITIZE ITS
LEAD
PROGRAM AND FOCUS OPERATIONS
* VTV THERAPEUTICS INC - ANNOUNCES WORKFORCE REDUCTION OF
65%
* VTV THERAPEUTICS INC - PRIORITIZATION OF LEAD PROGRAM
TTP399
* VTV THERAPEUTICS - PAUSED VTV'S DEVELOPMENT ACTIVITIES ON
HPP737, A PDE4 INHIBITOR FOR TREATMENT OF PSORIASIS, WHILE IT
EVALUATES STRATEGIC OPTIONS
* VTV THERAPEUTICS INC - CONTINUES TO SUPPORT DEVELOPMENT OF
ITS
PARTNERED PROGRAMS
* VTV THERAPEUTICS - CONTINUE TO ENGAGE WITH FDA TO MAP OUT
A
CLEAR AND POSITIVE PATH FORWARD ON TTP399 PHASE 3 PIVOTAL
STUDIES
Source text for Eikon: ID:nGNX6nMNwT
Further company coverage: VTVT.O
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)